五洲医疗
(301234)
| 流通市值：42.25亿 | | | 总市值：71.26亿 |
| 流通股本：4031.80万 | | | 总股本：6800.00万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 300,169,207.11 | 203,045,041.05 | 100,616,784.24 | 458,282,116.04 |
| 营业总成本 | 288,854,890.71 | 192,762,378.66 | 95,348,895.49 | 441,702,032.61 |
| 其他经营收益 | | | | |
| 营业利润 | 20,801,987.36 | 17,467,993.65 | 9,250,544.23 | 23,521,219.29 |
| 利润总额 | 20,444,566.41 | 17,359,506.25 | 9,185,078.33 | 22,893,216.81 |
| 净利润 | 17,532,648.01 | 15,363,370.79 | 8,050,981.45 | 18,893,021.58 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 17,532,648.01 | 15,363,370.79 | 8,050,981.45 | 18,893,021.58 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 567,113,941.74 | 557,549,524.81 | 555,285,000.94 | 573,742,416.04 |
| 非流动资产: | | | | |
| 非流动资产合计 | 298,248,002.16 | 297,871,240.86 | 298,691,303.97 | 295,295,748.28 |
| 资产总计 | 865,361,943.9 | 855,420,765.67 | 853,976,304.91 | 869,038,164.32 |
| 流动负债: | | | | |
| 流动负债合计 | 84,771,128.69 | 76,694,962.59 | 68,763,360.42 | 91,508,518.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 15,584,271.41 | 15,888,536.5 | 16,143,599.67 | 16,511,282.89 |
| 负债合计 | 100,355,400.1 | 92,583,499.09 | 84,906,960.09 | 108,019,800.95 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 765,006,543.8 | 762,837,266.58 | 769,069,344.82 | 761,018,363.37 |
| 股东权益合计 | 765,006,543.8 | 762,837,266.58 | 769,069,344.82 | 761,018,363.37 |
| 负债和股东权益合计 | 865,361,943.9 | 855,420,765.67 | 853,976,304.91 | 869,038,164.32 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 358,706,519.93 | 237,820,239.2 | 114,039,867.26 | 530,168,112.73 |
| 经营活动现金流出小计 | 319,077,064.07 | 209,341,210.68 | 114,855,626.83 | 456,783,203.04 |
| 经营活动产生的现金流量净额 | 39,629,455.86 | 28,479,028.52 | -815,759.57 | 73,384,909.69 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,077,211,532.82 | 708,563,006.39 | 241,060,871.23 | 1,128,736,994.16 |
| 投资活动现金流出小计 | 1,123,533,014.53 | 755,524,915 | 280,901,790 | 1,257,176,292.99 |
| 投资活动产生的现金流量净额 | -46,321,481.71 | -46,961,908.61 | -39,840,918.77 | -128,439,298.83 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 13,744,467.58 | 13,744,467.58 | - | 20,988,907.54 |
| 筹资活动产生的现金流量净额 | -13,744,467.58 | -13,744,467.58 | - | -20,988,907.54 |
| 汇率变动对现金及现金等价物的影响 | -2,713,491.7 | -1,968,454.8 | -1,048,093.84 | 806,486.26 |
| 现金及现金等价物净增加额 | -23,149,985.13 | -34,195,802.47 | -41,704,772.18 | -75,236,810.42 |
| 期末现金及现金等价物余额 | 55,025,326.98 | 43,979,509.64 | 36,470,539.93 | 78,175,312.11 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -34,195,802.47 | - | -75,236,810.42 |